Further good news from prophylactic human papillomavirus vaccines: long-term duration of immunity

ISSN： 1745-5057

Source： Women's Health, Vol.6, Iss.3, 2010-05, pp. : 361-363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prophylactic human papillomavirus vaccine

By Paavonen Jorma Lehtinen Matti

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 5-6

Future Medicine

Access to resources Recommend Favorite

Prophylactic human papillomavirus vaccines to prevent cervical cancer: review of the Phase II and III trials

By Harper Diane M

Therapy, Vol. 5, Iss. 3, 2008-05 ,pp. : 313-324

Future Medicine

Access to resources Recommend Favorite

Human papillomavirus vaccines and vaccine implementation

By de Sanjosé Silvia Alemany Laia Castellsagué Xavier Bosch F Xavier

Women's Health, Vol. 4, Iss. 6, 2008-11 ,pp. : 595-604

Future Medicine

Access to resources Recommend Favorite

Human papillomavirus vaccines: Understanding the benefit-risk

By Neels Pieter

Annals of Medicine, Vol. 45, Iss. 3, 2013-05 ,pp. : 203-205

Informa Healthcare

Access to resources Recommend Favorite

Long‐term outcome of prophylactic thyroidectomy in children carrying RET germline mutations

BRITISH JOURNAL OF SURGERY, Vol. 105, Iss. 2, 2018-01 ,pp. : e150-e157

John Wiley & Sons Inc

Access to resources Recommend Favorite